The off-label drug use in oncology and hematology with emphasis on age groups

Journal Title: Współczesna Onkologia - Year 2005, Vol 9, Issue 9

Abstract

Drug approval refers to indications, patient characteristics, dosage, route of administration, contraindications and warnings. The term „off-label prescribing” refers to the use of a drug outside the terms of its marketing authorization, including prescribing for an unlicensed indication. In this review, we analyzed the extent of the off-label use in childhood and adult hemato-oncology patients, based on the PubMed database. Prescribing for non-approved uses is widespread in different medicine areas. The frequency of off-label prescriptions among pediatric oncological patients was estimated to be 36-46%, whereas for adult patients with cancer at the level 22-33%. The most common reasons for the off-label use in children were lack of adequate formulations, which facilitate administration of the doses which small children require and lack of drug registration for children while registration for adult patients is completed. In adults, most common reasons were related to indications, dosage and route of drug administration. The off-label drug use creates an important medical, economic and ethical problem and also causes therapy reimbursement difficulties. This problem requires immediate regulatory intervention, but also a more evidence-based therapeutic approach. Possibilities of solving the off-label use include shortening of the drug approval process and faster update process related to results of new clinical trials.

Authors and Affiliations

Lidia Gil, Jan Styczyński, Mieczysław Komarnicki

Keywords

Related Articles

Analiza czynników prognostycznych u chorych na raka wpustu leczonych operacyjnie

Cel pracy: Analiza przeżyć chorych z rakiem wpustu w zależności od czynników związanych z biologią nowotworu oraz czynników zależnych od chirurga. Materiał i metody: W latach 1988–2000, u 59 chorych wykonano całkowitą r...

Application of combined positron emission tomography and computed tomography in the diagnosis of recurrent gastrointestinal stromal tumor and assessment of the efficacy imatinib therapy - a case report

Combined positron emission tomography and computed tomography (PET/CT) with the use of F-18-fluorodeoxyglucose (FDG) is one of the most modern imagining methods producing images of the entire body or selected human org...

Skrajna hiponatremia w przebiegu zespołu niedostosowanego wydzielania hormonu antydiuretycznego (SIADH) u chorego na drobnokomórkowego raka płuca – opis przypadku i przegląd piśmiennictwa

Wstęp: Celem pracy jest przedstawienie przypadku pełnoobjawowego zespołu SIADH ze skrajną hiponatremią u chorego na drobnokomórkowego raka płuca w początkowym etapie leczenia cytostatykami. Opis przypadku: 64-letniego m...

Download PDF file
  • EP ID EP82314
  • DOI -
  • Views 76
  • Downloads 0

How To Cite

Lidia Gil, Jan Styczyński, Mieczysław Komarnicki (2005). The off-label drug use in oncology and hematology with emphasis on age groups. Współczesna Onkologia, 9(9), 404-407. https://europub.co.uk./articles/-A-82314